If you liked this article you might like

Novartis Passes FDA Blood Cancer Panel 'With Flying Colors,' Gives Positive Read Through For Others

Landmark Novartis Immunotherapy Faces Crucial FDA Hearing Wednesday

Biotech Movers: NewLink, Inovio, Juno